Delivery Order SPE2DB20D3103-SPE2DB24FM4E6
Award Date
1/25/24
Potential Completion Date
1/26/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,242.96 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the supply of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. The completion date for this order is February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $1,442.25 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
The Defense Logistics Agency (DLA) awarded a $4,973.03 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM. The contract is for the delivery of pharmaceutical products and has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This order is part of a larger indefinite delivery contract (IDC) awarded by...
Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc., was awarded a $1,693.50 firm fixed price delivery order from the Defense Logistics Agency (DLA) on February 23, 2024. The order is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a completion date of February 26, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order contract worth $4,326.75 by the Defense Logistics Agency Troop Support Medical to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceutical supplies. This contract has a completion date of February 12, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the Defense Logistics Agency valued at up to $999,999,999.00...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract (SPE2DX15D1053|SPE2DX24F6HZX) by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to provide 4,563,943,667 units of Fluticasone Prop HFA 110 MCG 12GM. The $1,623.07 award has an ultimate completion date of March 13, 2024 and does not utilize a set-aside designation. This delivery order contract is part of a larger...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,091.40 for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,923.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563652915 - FLUTICASONE PROP HFA 220 MCG 12GM. This contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not associated with any set-aside program. In addition, Amerisourcebergen Drug...
This federal contract award is a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,238.15, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The contract has an ultimate completion date of April 3, 2024 and does not include a set-aside designation....